The Journal of Bone and Joint Surgery (American). 2006;88:267-272.
doi:10.2106/JBJS.E.00051
© 2006 The Journal of Bone and Joint Surgery, Inc.
Three-Year Changes in Bone Mineral Density Around the Knee After a Six-Month Course of Oral Alendronate Following Total Knee Arthroplasty
A Prospective, Randomized Study
Ching-Jen Wang, MD1,
Jun-Wen Wang, MD1,
Jih-Yang Ko, MD1,
Lin-Hsiu Weng, MD1 and
Chung-Cheng Huang, MD1
1 Departments of Orthopedic Surgery (C.-J.W., J.-W.W., J.-Y.K., and L.-H.W.) and
Diagnostic Radiology (C.-C.H.), Chang Gung Memorial Hospital at Kaohsiung, 123
Ta-Pei Road, Niao-Sung Hsiang, Kaohsiung, Taiwan 833. E-mail address for C.-J.
Wang:
w281211{at}adm.cgmh.org.tw
Investigation performed at the Departments of Orthopedic Surgery and
Diagnostic Radiology, Chang Gung Memorial Hospital, Kaohsiung, Taiwan
In support of their research for or preparation of this manuscript, one or
more of the authors received grants or outside funding from the National
Science Council (NSC89-2314-13-182A-188) and Chang Gung Research Fund
(CMRP-1026). None of the authors received payments or other benefits or a
commitment or agreement to provide such benefits from a commercial entity. No
commercial entity paid or directed, or agreed to pay or direct, any benefits
to any research fund, foundation, educational institution, or other charitable
or nonprofit organization with which the authors are affiliated or
associated.
Background: Bone mineral density decreases after total knee
arthroplasty and is believed to affect prosthetic fixation. Treatment with
alendronate has been shown to improve short-term bone mineral density after
total knee arthroplasty; however, the long-term effects of this therapy are
unknown. The purpose of this study was to evaluate the long-term effects of a
six-month course of alendronate on bone mineral density after total knee
arthroplasty.
Methods: Sixty patients were randomly assigned to receive either
oral alendronate at a dosage of 10 mg/day for six months or no alendronate.
The bone mineral density in the distal aspect of the femur and the proximal
aspect of the tibia was measured preoperatively and at six, twelve, and
thirty-six months after total knee arthroplasty.
Results: Fifty-four patients (twenty-nine in the alendronate group
and twenty-five in the control group) completed the study. The alendronate
group showed significant increases in bone mineral density in the distal
aspect of the femur compared with the controls at six months (+4.8% and
14.2%, respectively; p < 0.01) and twelve months (+1.6% and
11.5%, respectively; p < 0.01). No significant difference in bone
mineral density was detected between the groups at thirty-six months
(3.9% and 12.2%, respectively; p = 0.08). Similar trends in bone
mineral density changes were also observed in the proximal aspect of the
tibia.
Conclusions: A six-month course of alendronate initially increased
bone mineral density at six and twelve months after total knee arthroplasty,
but no difference was noted after thirty-six months. The effect of alendronate
on bone mineral density after total knee arthroplasty may be limited after
discontinuation of therapy.
Level of Evidence: Therapeutic Level I. See Instructions
to Authors for a complete description of levels of evidence.

CiteULike Connotea Del.icio.us Technorati What's this?
|